Sample request
/ inquiry
KO

About

Biosolyx Co., Ltd. is a research-oriented company that creates value for our customers

History

2026
  • Registered a patent for ionizable lipids used in LNP production
  • Filed patent applications for LNP production composition and formulation
2025
  • Filed a US patent application for anti-cancer composition
  • Launched LNP encapsulation services
2024
  • Conducted joint research with K-MEDI hub (Development of vaccines and immune adjuvants)
  • Developed ionizable lipids for Lipid Nanoparticle (LNP) production
2023
  • Secured a patent for anti-cancer composition material
  • Signed an MOU for gene delivery system development
  • Conducted a research project on animal gene delivery systems with Kyungpook National University College of Veterinary Medicine
  • Registered a patent for gene delivery vehicle manufacturing
2022
  • Awarded as a Daegu-Gyeongbuk High-Tech Venture Industry Awards Venture Company
  • MOU on the development of vaccines to prevent animal diseases signed
  • Joint research agreement for the development of pulmonary fibrosis treatment signed
  • Excellent technology evaluation company (TCB) T-3 Level Certification
  • KRW 300 million in seed investment attracted
2021
  • Production Technology Research Institute product certification
  • Gene delivery material patent registration
2020
  • Venture Business Certification
  • Selected as a TIPS project for start-up growth technology development project
  • Established affiliated research institute
2019
  • Biosolyx Co., Ltd. Establishment
  • Attracted KRW 150 million in seed investment